Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Thermogenesis Holdings: Rises on plans to develop COVID-19 test kit

** Shares of cell-based therapy co  THMO.O  more than double
to $6.10 - set for biggest one-day pct jump in over 3 yrs
    ** Co says working with ImmuneCyte to develop, register,
import and seek U.S. FDA approval for an advanced point-of-care
test to diagnose COVID-19
    ** Separately, co reports a 35% rise in 2019 net revenue to
$13 mln, helped by demand for its cell therapy products AXP and
CAR-TXpress  urn:newsml:reuters.com:*:nPn3J5lPya
    ** Including session's gain, THMO has risen ~42% YTD 

 (Reporting by Vishwadha Chander in Bengaluru)
 ((vishwadha.chander@thomsonreuters.com))

Recent news on Thermogenesis Holdings

See all news